Firy Inc. vs 10X Genomics Inc — how do they compare? Firy Inc. trades at $8.4 (market cap $125.48M), while 10X Genomics Inc trades at $42.6 (market cap $5.81B). The key difference: 10X Genomics Inc is far larger — about 46.3× Firy Inc.'s market cap, and 10X Genomics Inc is trading nearer its 52-week high, Firy Inc. nearer its low. Which is the better fit depends on your goals.
| FIRY | TXG | |
|---|---|---|
Market Cap | $125.48M | $5.81B |
Sector | Consumer Cyclical | Health |
52-Week High | $12.45 | $45.80 |
52-Week Low | $2.28 | $11.34 |
Enterprise Value | $69.16M | $5.35B |
Signals from Pluang's Aura AI — not financial advice
FIRY trades at $8.39, up 4.35% today, with a bullish technical signal from moving averages and RSI near oversold levels. The company recently rebranded from Skillz Inc. and reported Q1 2026 revenue growth but continues significant losses, with a net income margin of -57.48%. Cash flow remains negative, though operating losses have narrowed from prior years.
Outlook is mixed: technical momentum and revenue stabilization offer potential upside, but persistent losses, negative cash flow, and weak profitability metrics pose substantial risks. Analyst consensus is neutral with 60% hold ratings, reflecting cautious optimism amid ongoing financial challenges.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Firy Inc. operates a mobile gaming platform in the United States, Israel, China, Malta, Hong Kong, Cyprus, and other international markets. The company operates through two segments: Skillz and RZR. Its Skillz platform enables game developers to monetize their content by integrating real-money tournaments, virtual prizes, and social competition features directly into multiplayer games.
Read more on FIRY →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →